Camela, E.; Villani, A.; Ocampo Garza, S. S.; Costa, C.; Fabbrocini, G.; Megna, M.; Potestio, L.; Ruggiero, A.; Scalvenzi, M. Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-ID Questionnaire. Dermatol Pract Concept 2023, 13 (3), e2023177. https://doi.org/10.5826/dpc.1303a177.